Clinical Trials Directory

Trials / Unknown

UnknownNCT06230016

Adhesion of Children and Adolescents Treated for Cancer to Personalized Support in Adapted Physical Activity Program

Evaluation of the Adhesion of Children and Adolescents Treated for Cancer to Personalized Support in Adapted Physical Activity

Status
Unknown
Phase
Study type
Observational
Enrollment
48 (estimated)
Sponsor
University Hospital, Grenoble · Academic / Other
Sex
All
Age
3 Years – 17 Years
Healthy volunteers
Not accepted

Summary

Adapted physical activity session with a formed professional is proposed in standard care since 2022 in the immuno-hematological service to all children with newly diagnosed cancer or relapse. The aim of this study is to keep the children in the APA programm during all the treatment lenght. This study aims to evaluate by questionnaires the motivation keys and restraint from children and parents before the APA program starts (at diagnosis or relapse if not previously participating to an APA programm) and after 4 to 6 months of APA programm. The final expected fallout is to enhance children adhesion to long term APA program by implementing tools in current practice to overcome restraints from young patients and their parents

Detailed description

The literature and the French Cancer Plan confirm the benefits of physical activity for cancer patients, and underline the importance of developing appropriate physical activity support for children and adolescents, given their specific needs and the societal and public health challenge represented by these budding patients. Despite the abundance of studies relating to physical activity in oncology, few data are available, particularly in the pediatric and adolescent/young adult population : * on physical activity interventions initiated early and sustained over time * on personalized physical activity interventions integrated into the patient's care/life trajectory * on factors favoring adhesion to an adapted physical activity program \[APA\] during and/or after cancer treatment This is a prospective, exploratory, monocentric study to explore these points. As part of routine management in the immunohaemato-oncology \[IHO\] department of the Grenoble Alpes University Hospital, a personalized physical activity \[PA\] program is systematically proposed by a PA professional, with a program adapted to the child, his or her motivations and limitations. As part of the protocol, a questionnaire-based assessment of motivations and obstacles, as well as quality of life, will be carried out at the start of the PA program and again after 4 to 6 months. Criteria for adherence to the APA program will also be collected. EXPECTED OUTPUTS * Propose an organizational model in pediatric oncology for the early and sustained practice of APA with children and adolescents hospitalized for cancer. * Finalize assessment and follow-up materials for children receiving APA support in pediatric oncology (information leaflets, certificate of no contra-indication to APA, assessment and follow-up form, questionnaire on attitude and motivation to APA, etc.). * Provide guidance to help young cancer patients adhere more effectively to APA program. * Participate in the promotion of APA and the development of APA recommendations for children and adolescents treated for cancer, in conjunction with the SFCE (Children Cancer French Society) national working group on APA for children and adolescents with cancer.

Conditions

Interventions

TypeNameDescription
OTHERquestionnaireshuman and social science questionnaire (specifically designed by the expert lab of Grenoble) on motivation and restraint perceived by patient and parents, elaborated especially for this study. Questionnaire administred before the start of current care APA programm and after 4 to 6 months.
OTHERPedsQL quality of life questionnairesvalidated PedsQL (The Pediatric Quality of Life Inventory) questionnaires administred to children (if adequate) and parents before the start of current care APA programm and after 4 to 6 months

Timeline

Start date
2024-02-16
Primary completion
2025-08-16
Completion
2026-01-31
First posted
2024-01-29
Last updated
2024-09-23

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT06230016. Inclusion in this directory is not an endorsement.